Fibromyalgia Treatment Drug Market 2027 By Drug Class, Distribution Channel and Geography | The Insight Partners

Fibromyalgia Treatment Drug Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class (Antidepressants, Selective serotonin reuptake inhibitors, Tricyclics); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00016861 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Fibromyalgia is a disorder characterized by a musculoskeletal pain with sleep, memory and mood issues. The symptoms of fibromyalgia often start gradually and get severe with time. Women are more susceptible to develop fibromyalgia than men. The people who have fibromyalgia also develop symptoms like headache, irritable bowel syndrome, anxiety, and temporomandibular joint. Various drug class available for fibromyalgia treatment like, antidepressants, tricyclics, SSRIs.

MARKET DYNAMICS

The key market drivers for Fibromyalgia Treatment Drug Market Includes, rising incidences of traumatic stress and road accidents. Additionally, growing incidences of rheumatic disease and growing geriatric population across the globe is also a driving factor for the market. Whereas, difficulty in fibromyalgia diagnosis as well as possible side effects from the treatment are the restraining factor for the market.

MARKET SCOPE

The "Fibromyalgia Treatment Drug Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Fibromyalgia Treatment Drug market with detailed market segmentation by drug class and distribution channel. The Fibromyalgia Treatment Drug Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Fibromyalgia Treatment Drug Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Fibromyalgia Treatment Drug Market is segmented on the basis of drug class and distribution channel. On the basis of drug class the market is segmented as, antidepressants, SSRIs, tricyclics. On the basis of distribution channel the market is segmented as, hospital pharmacies, retail pharmacies and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Fibromyalgia Treatment Drug Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Fibromyalgia Treatment Drug Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Fibromyalgia Treatment Drug Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Fibromyalgia Treatment Drug Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Fibromyalgia Treatment Drug Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Fibromyalgia Treatment Drug Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Fibromyalgia Treatment Drug market in the global market. Below mentioned is the list of few companies engaged in the Fibromyalgia Treatment Drug Market.

The report also includes the profiles of key players in Fibromyalgia Treatment Drug Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Eli Lilly and Company
  •   Pfizer, Inc
  •   Novartis AG
  •   Allergan plc
  •   Sun Pharmaceutical Industries Ltd
  •   Aptinyx, Inc
  •   Prismic Pharmaceuticals, Inc
  •   Innovative Med Concepts, Inc
  •   Intec Pharma Ltd
  •   Astellas Pharma Inc

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Fibromyalgia Treatment Drug Market - By Drug Class
1.3.2 Fibromyalgia Treatment Drug Market - By Distribution Channel
1.3.3 Fibromyalgia Treatment Drug Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. FIBROMYALGIA TREATMENT DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. FIBROMYALGIA TREATMENT DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. FIBROMYALGIA TREATMENT DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. FIBROMYALGIA TREATMENT DRUG - GLOBAL MARKET OVERVIEW
6.2. FIBROMYALGIA TREATMENT DRUG - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. FIBROMYALGIA TREATMENT DRUG MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. ANTIDEPRESSANTS
7.3.1. Overview
7.3.2. Antidepressants Market Forecast and Analysis
7.3.3. duloxetine Market
7.3.3.1. Overview
7.3.3.2. duloxetine Market Forecast and Analysis
7.3.4. milnacipran Market
7.3.4.1. Overview
7.3.4.2. milnacipran Market Forecast and Analysis
7.4. SELECTIVE SEROTONIN REUPTAKE INHIBITORS
7.4.1. Overview
7.4.2. Selective serotonin reuptake inhibitors Market Forecast and Analysis
7.4.3. Citalopram Market
7.4.3.1. Overview
7.4.3.2. Citalopram Market Forecast and Analysis
7.4.4. Escitalopram Market
7.4.4.1. Overview
7.4.4.2. Escitalopram Market Forecast and Analysis
7.4.5. Fluvoxamine Market
7.4.5.1. Overview
7.4.5.2. Fluvoxamine Market Forecast and Analysis
7.4.6. Fluoxetine Market
7.4.6.1. Overview
7.4.6.2. Fluoxetine Market Forecast and Analysis
7.4.7. Paroxetine Market
7.4.7.1. Overview
7.4.7.2. Paroxetine Market Forecast and Analysis
7.5. TRICYCLICS
7.5.1. Overview
7.5.2. Tricyclics Market Forecast and Analysis
7.5.3. Amitriptyline Market
7.5.3.1. Overview
7.5.3.2. Amitriptyline Market Forecast and Analysis
8. FIBROMYALGIA TREATMENT DRUG MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis

9. FIBROMYALGIA TREATMENT DRUG MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Fibromyalgia Treatment Drug Market Overview
9.1.2 North America Fibromyalgia Treatment Drug Market Forecasts and Analysis
9.1.3 North America Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Drug Class
9.1.4 North America Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Fibromyalgia Treatment Drug Market
9.1.5.1.1 United States Fibromyalgia Treatment Drug Market by Drug Class
9.1.5.1.2 United States Fibromyalgia Treatment Drug Market by Distribution Channel
9.1.5.2 Canada Fibromyalgia Treatment Drug Market
9.1.5.2.1 Canada Fibromyalgia Treatment Drug Market by Drug Class
9.1.5.2.2 Canada Fibromyalgia Treatment Drug Market by Distribution Channel
9.1.5.3 Mexico Fibromyalgia Treatment Drug Market
9.1.5.3.1 Mexico Fibromyalgia Treatment Drug Market by Drug Class
9.1.5.3.2 Mexico Fibromyalgia Treatment Drug Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Fibromyalgia Treatment Drug Market Overview
9.2.2 Europe Fibromyalgia Treatment Drug Market Forecasts and Analysis
9.2.3 Europe Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Fibromyalgia Treatment Drug Market
9.2.5.1.1 Germany Fibromyalgia Treatment Drug Market by Drug Class
9.2.5.1.2 Germany Fibromyalgia Treatment Drug Market by Distribution Channel
9.2.5.2 France Fibromyalgia Treatment Drug Market
9.2.5.2.1 France Fibromyalgia Treatment Drug Market by Drug Class
9.2.5.2.2 France Fibromyalgia Treatment Drug Market by Distribution Channel
9.2.5.3 Italy Fibromyalgia Treatment Drug Market
9.2.5.3.1 Italy Fibromyalgia Treatment Drug Market by Drug Class
9.2.5.3.2 Italy Fibromyalgia Treatment Drug Market by Distribution Channel
9.2.5.4 Spain Fibromyalgia Treatment Drug Market
9.2.5.4.1 Spain Fibromyalgia Treatment Drug Market by Drug Class
9.2.5.4.2 Spain Fibromyalgia Treatment Drug Market by Distribution Channel
9.2.5.5 United Kingdom Fibromyalgia Treatment Drug Market
9.2.5.5.1 United Kingdom Fibromyalgia Treatment Drug Market by Drug Class
9.2.5.5.2 United Kingdom Fibromyalgia Treatment Drug Market by Distribution Channel
9.2.5.6 Rest of Europe Fibromyalgia Treatment Drug Market
9.2.5.6.1 Rest of Europe Fibromyalgia Treatment Drug Market by Drug Class
9.2.5.6.2 Rest of Europe Fibromyalgia Treatment Drug Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Fibromyalgia Treatment Drug Market Overview
9.3.2 Asia-Pacific Fibromyalgia Treatment Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Fibromyalgia Treatment Drug Market
9.3.5.1.1 Australia Fibromyalgia Treatment Drug Market by Drug Class
9.3.5.1.2 Australia Fibromyalgia Treatment Drug Market by Distribution Channel
9.3.5.2 China Fibromyalgia Treatment Drug Market
9.3.5.2.1 China Fibromyalgia Treatment Drug Market by Drug Class
9.3.5.2.2 China Fibromyalgia Treatment Drug Market by Distribution Channel
9.3.5.3 India Fibromyalgia Treatment Drug Market
9.3.5.3.1 India Fibromyalgia Treatment Drug Market by Drug Class
9.3.5.3.2 India Fibromyalgia Treatment Drug Market by Distribution Channel
9.3.5.4 Japan Fibromyalgia Treatment Drug Market
9.3.5.4.1 Japan Fibromyalgia Treatment Drug Market by Drug Class
9.3.5.4.2 Japan Fibromyalgia Treatment Drug Market by Distribution Channel
9.3.5.5 South Korea Fibromyalgia Treatment Drug Market
9.3.5.5.1 South Korea Fibromyalgia Treatment Drug Market by Drug Class
9.3.5.5.2 South Korea Fibromyalgia Treatment Drug Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Fibromyalgia Treatment Drug Market
9.3.5.6.1 Rest of Asia-Pacific Fibromyalgia Treatment Drug Market by Drug Class
9.3.5.6.2 Rest of Asia-Pacific Fibromyalgia Treatment Drug Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Fibromyalgia Treatment Drug Market Overview
9.4.2 Middle East and Africa Fibromyalgia Treatment Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Fibromyalgia Treatment Drug Market
9.4.5.1.1 South Africa Fibromyalgia Treatment Drug Market by Drug Class
9.4.5.1.2 South Africa Fibromyalgia Treatment Drug Market by Distribution Channel
9.4.5.2 Saudi Arabia Fibromyalgia Treatment Drug Market
9.4.5.2.1 Saudi Arabia Fibromyalgia Treatment Drug Market by Drug Class
9.4.5.2.2 Saudi Arabia Fibromyalgia Treatment Drug Market by Distribution Channel
9.4.5.3 U.A.E Fibromyalgia Treatment Drug Market
9.4.5.3.1 U.A.E Fibromyalgia Treatment Drug Market by Drug Class
9.4.5.3.2 U.A.E Fibromyalgia Treatment Drug Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Fibromyalgia Treatment Drug Market
9.4.5.4.1 Rest of Middle East and Africa Fibromyalgia Treatment Drug Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Fibromyalgia Treatment Drug Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Fibromyalgia Treatment Drug Market Overview
9.5.2 South and Central America Fibromyalgia Treatment Drug Market Forecasts and Analysis
9.5.3 South and Central America Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Fibromyalgia Treatment Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Fibromyalgia Treatment Drug Market
9.5.5.1.1 Brazil Fibromyalgia Treatment Drug Market by Drug Class
9.5.5.1.2 Brazil Fibromyalgia Treatment Drug Market by Distribution Channel
9.5.5.2 Argentina Fibromyalgia Treatment Drug Market
9.5.5.2.1 Argentina Fibromyalgia Treatment Drug Market by Drug Class
9.5.5.2.2 Argentina Fibromyalgia Treatment Drug Market by Distribution Channel
9.5.5.3 Rest of South and Central America Fibromyalgia Treatment Drug Market
9.5.5.3.1 Rest of South and Central America Fibromyalgia Treatment Drug Market by Drug Class
9.5.5.3.2 Rest of South and Central America Fibromyalgia Treatment Drug Market by Distribution Channel

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. FIBROMYALGIA TREATMENT DRUG MARKET, KEY COMPANY PROFILES
11.1. ELI LILLY AND COMPANY
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PFIZER, INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NOVARTIS AG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ALLERGAN PLC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. SUN PHARMACEUTICAL INDUSTRIES LTD
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. APTINYX, INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PRISMIC PHARMACEUTICALS, INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. INNOVATIVE MED CONCEPTS, INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. INTEC PHARMA LTD
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ASTELLAS PHARMA INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Eli Lilly and Company
2. Pfizer, Inc
3. Novartis AG
4. Allergan plc
5. Sun Pharmaceutical Industries Ltd
6. Aptinyx, Inc
7. Prismic Pharmaceuticals, Inc
8. Innovative Med Concepts, Inc
9. Intec Pharma Ltd
10. Astellas Pharma Inc.
TIPRE00016861
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking